{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T23:46:14Z","timestamp":1776210374573,"version":"3.50.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T00:00:00Z","timestamp":1764374400000},"content-version":"am","delay-in-days":301,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["2P30CA016058-45"],"award-info":[{"award-number":["2P30CA016058-45"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.clgc.2024.102258","type":"journal-article","created":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T12:47:44Z","timestamp":1730465264000},"page":"102258","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Impact of Preoperative Systemic Therapy on Cytoreductive Nephrectomy Outcomes in the National Surgical Quality Improvement Program (NSQIP)"],"prefix":"10.1016","volume":"23","author":[{"given":"Shawn","family":"Dason","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajvi","family":"Goradia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor","family":"Heh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akshay","family":"Sood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0451-5821","authenticated-orcid":false,"given":"Matthew","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6730-7697","authenticated-orcid":false,"given":"Young","family":"Son","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanquan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6166-2807","authenticated-orcid":false,"given":"Shang-Jui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elshad","family":"Hasanov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tasha","family":"Posid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3991-0696","authenticated-orcid":false,"given":"Eric A.","family":"Singer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clgc.2024.102258_bib0001","article-title":"State of the art: multidisciplinary management of oligometastatic renal cell carcinoma","volume":"43","author":"Dason","year":"2023","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.clgc.2024.102258_bib0002","doi-asserted-by":"crossref","first-page":"2957","DOI":"10.1200\/JCO.22.00868","article-title":"Management of metastatic clear cell renal cell carcinoma: ASCO Guideline","volume":"40","author":"Rathmell","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clgc.2024.102258_bib0003","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1097\/01.ju.0000110610.61545.ae","article-title":"Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis","volume":"171","author":"Flanigan","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.clgc.2024.102258_bib0004","doi-asserted-by":"crossref","first-page":"4508","DOI":"10.1200\/JCO.2019.37.15_suppl.4508","article-title":"Cytoreductive nephrectomy (CN) in metastatic renal cancer (mRCC): update on carmena trial with focus on intermediate IMDC-risk population","volume":"37","author":"Mejean","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clgc.2024.102258_bib0005","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1001\/jamaoncol.2018.5543","article-title":"Comparison of immediate vs deferred cytoreductive nephrectomy in patients with synchronous metastatic renal cell carcinoma receiving sunitinib: the SURTIME Randomized Clinical Trial","volume":"5","author":"Bex","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.clgc.2024.102258_bib0006","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1200\/JCO.2023.41.6_suppl.691","article-title":"Assessment of surgical complications in patients with metastatic clear cell renal cell carcinoma (mccRCC) receiving perioperative cabozantinib and nivolumab on Cyto-KIK clinical trial","volume":"41","author":"Runcie","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clgc.2024.102258_bib0007","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/s12885-024-11987-3","article-title":"Multicenter randomized trial of deferred cytoreductive nephrectomy in synchronous metastatic renal cell carcinoma receiving checkpoint inhibitors: the NORDIC-SUN-Trial","volume":"24","author":"Iisager","year":"2024","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.clgc.2024.102258_bib0008","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3233\/KCA-210010","article-title":"\u201cPROBE\u201ding the role of cytoreductive nephrectomy in advanced renal cancer","volume":"6","author":"Bell","year":"2022","journal-title":"Kidney Cancer J"},{"key":"10.1016\/j.clgc.2024.102258_bib0009","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.euo.2022.07.002","article-title":"Oncological outcomes of delayed nephrectomy after optimal response to immune checkpoint inhibitors for metastatic renal cell carcinoma","volume":"5","author":"Pignot","year":"2022","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.clgc.2024.102258_bib0010","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.bulcan.2024.03.002","article-title":"Cons\u00e9quences chirurgicales et anatomopathologiques de l'immunoth\u00e9rapie pr\u00e9op\u00e9ratoire en onco-urologie","volume":"111","author":"Lyoubi","year":"2024","journal-title":"Bulletin du Cancer"},{"key":"10.1016\/j.clgc.2024.102258_bib0011","doi-asserted-by":"crossref","first-page":"4704","DOI":"10.3390\/curroncol31080351","article-title":"Impact of timing of immunotherapy and cytoreductive nephrectomy in metastatic renal cell carcinoma: real-world data on survival outcomes from the CKCis database","volume":"31","author":"Park","year":"2024","journal-title":"Current Oncol"},{"key":"10.1016\/j.clgc.2024.102258_bib0012","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s11523-024-01065-w","article-title":"Real-world impact of upfront cytoreductive nephrectomy in metastatic non-clear cell renal cell carcinoma treated with first-line immunotherapy combinations or tyrosine kinase inhibitors (a sub-analysis from the ARON-1 Retrospective Study)","volume":"19","author":"Fiala","year":"2024","journal-title":"Targeted Oncol"},{"key":"10.1016\/j.clgc.2024.102258_bib0013","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.euo.2023.10.002","article-title":"Characterization of patients with metastatic renal cell carcinoma undergoing deferred, upfront, or no cytoreductive nephrectomy in the era of combination immunotherapy: results from the international metastatic renal cell carcinoma database consortium","volume":"7","author":"Takemura","year":"2024","journal-title":"Europ Urol Oncol"},{"key":"10.1016\/j.clgc.2024.102258_bib0014","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1001\/jamaoncol.2023.5269","article-title":"Immune checkpoint inhibitor therapy before nephrectomy for locally advanced and metastatic renal cell carcinoma: a review","volume":"10","author":"Ghoreifi","year":"2024","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.clgc.2024.102258_bib0015","doi-asserted-by":"crossref","first-page":"32.e39","DOI":"10.1016\/j.urolonc.2023.12.003","article-title":"Surgical outcomes of cytoreductive nephrectomy in patients receiving systemic immunotherapy for advanced renal cell carcinoma","volume":"42","author":"Reese","year":"2024","journal-title":"Urol Oncol"},{"key":"10.1016\/j.clgc.2024.102258_bib0016","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.euros.2023.01.016","article-title":"Cytoreductive nephrectomy following immune checkpoint inhibitor therapy is safe and facilitates treatment-free intervals","volume":"50","author":"Shapiro","year":"2023","journal-title":"Europ Urol Open Sci"},{"key":"10.1016\/j.clgc.2024.102258_bib0017","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.urolonc.2019.08.012","article-title":"Pathologic response and surgical outcomes in patients undergoing nephrectomy following receipt of immune checkpoint inhibitors for renal cell carcinoma","volume":"37","author":"Singla","year":"2019","journal-title":"Urol Oncol"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767324002283?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767324002283?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T15:19:40Z","timestamp":1753111180000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767324002283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S1558767324002283"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2024.102258","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of Preoperative Systemic Therapy on Cytoreductive Nephrectomy Outcomes in the National Surgical Quality Improvement Program (NSQIP)","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2024.102258","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102258"}}